Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer.
about
Long noncoding RNA MEG3, a potential novel biomarker to predict the clinical outcome of cancer patients: a meta-analysis.Extracellular Vesicles Arising from Apoptotic Cells in Tumors: Roles in Cancer Pathogenesis and Potential Clinical Applications.Quantitation of putative colorectal cancer biomarker candidates in serum extracellular vesicles by targeted proteomics.Molecular analyses of prostate tumors for diagnosis of malignancy on fine-needle aspiration biopsies.Mass spectrometry based proteomics analyses in kallikrein-related peptidase research: implications for cancer research and therapy.Extracellular Vesicles in Prostate Cancer Carcinogenesis, Diagnosis, and Management.
P2860
Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Targeted proteomics in urinary ...... prognosis of prostate cancer.
@en
Targeted proteomics in urinary ...... prognosis of prostate cancer.
@nl
type
label
Targeted proteomics in urinary ...... prognosis of prostate cancer.
@en
Targeted proteomics in urinary ...... prognosis of prostate cancer.
@nl
prefLabel
Targeted proteomics in urinary ...... prognosis of prostate cancer.
@en
Targeted proteomics in urinary ...... prognosis of prostate cancer.
@nl
P2093
P2860
P50
P356
P1433
P1476
Targeted proteomics in urinary ...... d prognosis of prostate cancer
@en
P2093
Alex Campos
Andreas Doll
Eduard Sabidó
Inés de Torres
Iolanda Garcia-Grau
Irene Bijnsdorp
Jaume Reventós
Juan Morote
Marina Rigau
Melania Montes
P2860
P304
P356
10.18632/ONCOTARGET.13634
P407
P577
2017-01-01T00:00:00Z